Both in Pharmaceuticals

Nektar Therapeutics vs Avalyn Pharma

Over the past year NKTR returned −46.3% and AVLN returned −19.2%; their daily moves had a correlation of 0.37.

NKTR −46.3% AVLN −19.2%Growth of $1, one year, split-adjusted
MetricNKTRAVLN
Price$37.45$27.14
Market cap$1.28B$1.20B
Today+0.62%+4.22%
1 month−34.4%−3.3%
6 months−56.8%—
Year to date−11.4%—
1 year−41.2%—
Revenue growth (YoY)−9.3%—
Gross margin100.0%—
Net margin−401.0%—
P/E (TTM)——
Price / sales23.4×—
Net cash$684.3M$337.6M
Dividend yield——
Volatility (60d)70.0%—
Short % of float21.0%11.6%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).